The therapeutics ETFs that returned most
See 5 funds ranked by total return with distributions reinvested, one year. Updated Oct 20, 2026. Funds on one theme can hold different companies, so the gap from top to bottom of this list reflects what they own, not the theme.
Ask IQ about this page
Ask IQ about the therapeutics ETFs that returned mostAnswers cite the figures on this page.
| # | Ticker | Fund | Total return, 1Y ↓ | vs its benchmark 1Y | Weight in S&P 500 companies | Fee |
|---|---|---|---|---|---|---|
| 1 | CANC | Tema Oncology ETF | +36.5% | not measured | 21.9% | 0.75% |
| 2 | IBRN | iShares Neuroscience and Healthcare ETF | +9.3% | not measured | 5.3% | 0.47% |
| 3 | PSIL | AdvisorShares Psychedelics ETF | +7.0% | not measured | 7.8% | 1.00% |
| 4 | MDEV | First Trust Indxx Medical Devices ETF | +4.4% | not measured | 47.4% | 0.70% |
| 5 | IHI | iShares U.S. Medical Devices ETF | −10.1% | not measured | 88.5% | 0.37% |
Method
The 5 of 5 ETFs in the therapeutics and medical devices theme with a full year of trading, highest first, each over the same year to Oct 20, 2026 with distributions reinvested. Across the funds listed here the one year total return runs from -10.1% to 36.5%.
The rest of the method
A year says what happened, not what happens next. The list sorts one published figure, with no scoring or weighting. Every fund ETFIQ covers in this category is eligible, closed funds included.
ETFIQ links to the documents behind every figure; a link is not an endorsement. A ranking is not a recommendation or an opinion.
Cite this pageCitation, APA and Markdown
ETFIQ, The therapeutics ETFs that returned most, ranked by total return with distributions reinvested, data as of Oct 20, 2026. https://etfiq.com/rankings/themes-best-year-therapeutics
ETFIQ. (Oct 20, 2026). The therapeutics ETFs that returned most, ranked by total return with distributions reinvested. Retrieved from https://etfiq.com/rankings/themes-best-year-therapeutics
[The therapeutics ETFs that returned most, ranked by total return with distributions reinvested (ETFIQ, Oct 20, 2026)](https://etfiq.com/rankings/themes-best-year-therapeutics)
Free to use with attribution for figures ETFIQ computes; issuer data stays under its owner's terms. The underlying files are at Open data.